EUVIMEDEUVIMED entdecken
Crossref

Large-scale metaproteomics of human gut microbiota reveals microbial functions in metabolic diseases and aging

Shuang Liang, Yingying Sun, Zelei Miao, Bang-Yan Li, Ziyuan Xing, Yuting Xie, Enci Cai, Sainan Li, Pu Liu, Min Yang, Menglei Shuai, Wanglong Gou und 11 weitere

Cell Metabolism · 2026-05 · 38 (5) · 995-1011.e6

DOI: 10.1016/j.cmet.2026.02.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2026-05. Verfasst von Shuang Liang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake U…. Hauptthemen laut MEDLINE: Aging, Proteomics, Gastrointestinal Microbiome, Metabolic Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Westlake Education Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The protein-level functionalities of the human gut microbiota in large populations, and their associations with host factors, remain unexplored. This study reports a metaproteomic study of 1,967 fecal samples from 1,399 middle-aged and elderly Chinese individuals, identifying microbial functions linked to 44 phenotypes. We uncover aging-associated functional shifts in carbon metabolism and energy production driven by species within the Bacillota, Bacteroidota, Actinomycetota, and Pseudomonadota. Across metabolic diseases, we observe the consistent depletion of Bacillota species and their proteins involved in carbohydrate, energy, amino acid metabolism, and short-chain fatty acid production. We also identify medication-associated features across diabetes, hypertension, and dyslipidemia. Validated in an independent cohort, Megasphaera elsdenii emerged as a hub species in type 2 diabetes. Experimental validation indicates that M. elsdenii is promoted by antidiabetic drugs and may regulate glucose homeostasis through butyrate production. This study provides protein-level evidence of microbial functions in health and disease, highlighting potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingProteomicsGastrointestinal MicrobiomeMetabolic DiseasesHumansAgedMiddle AgedFemaleFecesMaleDiabetes Mellitus, Type 2Megasphaera

Stichwörter der Autor:innen

Megasphaera elsdeniiagingdiabeteshuman gut microbiomemetaproteomics

Autor:innen und Institutionen

  • Affiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, Zhejiang Province, China; State Key Laboratory fo…
  • Affiliated Hangzhou First People's Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, Zhejiang Province, China; Westlake Center for Int…
  • Department of Epidemiology, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University, Guangzhou, China.
  • Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang Province, China.
  • Westlake Omics (Hangzhou) Biotechnology Co., Ltd., No. 1 Yunmeng Road, Cloud Town, Xihu District, Hangzhou, Zhejiang Province 310024, China.
  • First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China.

Förderung

  • National Key Research and Development Program of China
  • Westlake Education Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Liang, S., Sun, Y., Miao, Z., Li, B. Y., Xing, Z., Xie, Y., Cai, E., Li, S., Liu, P., Yang, M., Shuai, M., Gou, W., Jiang, W., Wang, Y., Gao, H., Zhang, K., Yu, J., Cai, X., Wang, X., …, & Guo, T. (2026). Large-scale metaproteomics of human gut microbiota reveals microbial functions in metabolic diseases and aging. Cell Metabolism, 38(5), 995-1011.e6. https://doi.org/10.1016/j.cmet.2026.02.012

Vancouver

Liang S, Sun Y, Miao Z, Li BY, Xing Z, Xie Y, et al. Large-scale metaproteomics of human gut microbiota reveals microbial functions in metabolic diseases and aging. Cell Metabolism. 2026;38(5):995-1011.e6. doi:10.1016/j.cmet.2026.02.012

BibTeX
@article{Liang2026,
  author = {Liang, Shuang and Sun, Yingying and Miao, Zelei and Li, Bang-Yan and Xing, Ziyuan and Xie, Yuting and Cai, Enci and Li, Sainan and Liu, Pu and Yang, Min and Shuai, Menglei and Gou, Wanglong and Jiang, Wenhao and Wang, Youming and Gao, Huanhuan and Zhang, Ke and Yu, Jing and Cai, Xue and Wang, Xingbing and Zhu, Yi and Chen, Yu-Ming and Zheng, Ju-Sheng and Guo, Tiannan},
  title = {Large-scale metaproteomics of human gut microbiota reveals microbial functions in metabolic diseases and aging},
  journal = {Cell Metabolism},
  year = {2026},
  volume = {38},
  number = {5},
  pages = {995--1011.e6},
  doi = {10.1016/j.cmet.2026.02.012}
}
Kostenlos starten →